微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 26.33% | -34.78% | -21.05% | 124/158 | 51.09% | 迪哲医药 | 97.73% | 行业排名> |
| 2023-12-31 | 33.36% | -0.2% | -1.43% | 109/158 | 50.95% | 百利天恒 | 97.99% | 行业排名> |
| 2023-09-30 | 33.84% | 1.81% | -5.57% | 109/158 | 32.68% | 百利天恒 | 98.92% | 行业排名> |
| 2023-06-30 | 35.84% | 6.69% | -11.25% | 110/158 | 38.38% | 迈威生物 | 98.93% | 行业排名> |
| 2023-03-31 | 40.38% | 5.4% | 20.82% | 98/158 | 52.8% | 迈威生物 | 99.59% | 行业排名> |
| 2022-12-31 | 33.42% | -24.24% | 0.55% | 112/158 | 53.22% | 迈威生物 | 99.8% | 行业排名> |
| 2022-09-30 | 33.24% | -29.22% | -1.04% | 108/158 | 6.55% | 迈威生物 | 99.46% | 行业排名> |
| 2022-06-30 | 33.59% | -34.88% | -12.33% | 110/158 | 21.05% | 迈威生物 | 99.75% | 行业排名> |
| 2022-03-31 | 38.31% | -32.85% | -13.16% | 100/158 | 54.35% | 迈威生物 | 99.67% | 行业排名> |
| 2021-12-31 | 44.11% | -21.64% | -6.07% | 90/158 | 54.83% | 迈威生物 | 99.44% | 行业排名> |
| 2021-09-30 | 46.96% | -19.37% | -8.95% | 80/158 | 46.94% | 迈威生物 | 98.57% | 行业排名> |
| 2021-06-30 | 51.58% | -12.62% | -9.59% | 77/158 | 47.41% | 首药控股 | 99.93% | 行业排名> |
| 2021-03-31 | 57.05% | -13.37% | 1.34% | 61/158 | 54.19% | 艾力斯 | 99.41% | 行业排名> |
| 2020-12-31 | 56.3% | -8.35% | -3.35% | 66/158 | -144.57% | 艾力斯 | 98.7% | 行业排名> |
| 2020-09-30 | 58.25% | -6.56% | -1.32% | 56/158 | 56.59% | 艾力斯 | 99.4% | 行业排名> |
| 2020-06-30 | 59.03% | -7.6% | -10.37% | 56/158 | 54.33% | 首药控股 | 99.94% | 行业排名> |
| 2020-03-31 | 65.86% | 0.12% | 7.22% | 36/158 | 55.6% | 泽璟制药 | 99.96% | 行业排名> |
| 2019-12-31 | 61.42% | -0.5% | -1.46% | 56/158 | -1204.19% | 微芯生物 | 95.14% | 行业排名> |
| 2019-09-30 | 62.33% | 1.96% | -2.43% | 42/158 | 55.54% | 多瑞医药 | 95.59% | 行业排名> |
| 2019-06-30 | 63.89% | 4.55% | -2.87% | 42/158 | 55.39% | 微芯生物 | 95.81% | 行业排名> |
| 2019-03-31 | 65.78% | 1.84% | 6.55% | 30/158 | 51.47% | 微芯生物 | 96.09% | 行业排名> |
| 2018-12-31 | 61.73% | 35.72% | 0.98% | 49/158 | -205.9% | 微芯生物 | 96.11% | 行业排名> |
| 2018-09-30 | 61.13% | 54.86% | 0.05% | 39/158 | 54.21% | 微芯生物 | 95.5% | 行业排名> |
| 2018-06-30 | 61.11% | 77.47% | -5.39% | 41/158 | 53.64% | 微芯生物 | 96.27% | 行业排名> |
| 2018-03-31 | 64.59% | 95.44% | 42% | 31/158 | 54.17% | 贝达药业 | 95.47% | 行业排名> |
| 2017-12-31 | 45.48% | 38.7% | 15.21% | 72/158 | 52.44% | 贝达药业 | 95.51% | 行业排名> |
| 2017-09-30 | 39.48% | 25.93% | 14.65% | 61/158 | 49.22% | 贝达药业 | 95.54% | 行业排名> |
| 2017-06-30 | 34.43% | 13.5% | 4.19% | 75/158 | 47.82% | 贝达药业 | 95.74% | 行业排名> |
| 2017-03-31 | 33.05% | 18.56% | 0.77% | 62/158 | 46.74% | 退市金泰 | 96.19% | 行业排名> |
| 2016-12-31 | 32.79% | 132.82% | 4.61% | 84/158 | 48.3% | 贝达药业 | 95.81% | 行业排名> |
| 2016-09-30 | 31.35% | 124.41% | 3.33% | 59/158 | 45.59% | 退市金泰 | 95.93% | 行业排名> |
| 2016-06-30 | 30.34% | 128.41% | 8.84% | 71/158 | 46.43% | 贝达药业 | 95.58% | 行业排名> |
| 2016-03-31 | 27.87% | 116.9% | 97.89% | 62/158 | 43.3% | 贝达药业 | 95.89% | 行业排名> |
| 2015-12-31 | 14.08% | 16.83% | 0.83% | 102/158 | 45.94% | 微芯生物 | 97.46% | 行业排名> |
| 2015-09-30 | 13.97% | 22.72% | 5.17% | 76/158 | 44.3% | 贝达药业 | 97.01% | 行业排名> |
| 2015-06-30 | 13.28% | 15.54% | 3.36% | 82/158 | 44.97% | 贝达药业 | 97.02% | 行业排名> |
| 2015-03-31 | 12.85% | 0.55% | 6.59% | 74/158 | 43.06% | 舒泰神 | 94.38% | 行业排名> |
| 2014-12-31 | 12.06% | -3.02% | 5.91% | 100/158 | 43.12% | -- | -- | 行业排名> |
| 2014-09-30 | 11.38% | -8.08% | -0.98% | 69/158 | 41.57% | -- | -- | 行业排名> |
| 2014-06-30 | 11.5% | -5.77% | -10.05% | 72/158 | 40.79% | -- | -- | 行业排名> |
| 2014-03-31 | 12.78% | -12.6% | 2.82% | 67/158 | 40.2% | -- | -- | 行业排名> |